Revolutionary research successes
Time and again, universities in Germany achieve revolutionary successes with their research. As happened for instance with the biopharma company BioNTech, which just a few years after being spun off from the university clinic of Johannes Gutenberg University Mainz was able to use its expertise in the field of mRNA technology to develop a COVID-19 vaccine. This vaccine was the first mRNA-based drug to be approved for use on humans, and the most rapidly approved vaccine against a new pathogen in the history of medicine. The Mainz-based spin-off thereby made an unimaginably important contribution to combating the coronavirus pandemic.